Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals: the REGICOR Study
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Dégano, Irene R.
- dc.contributor.author Camps-Vilaró, Anna
- dc.contributor.author Subirana Cachinero, Isaac
- dc.contributor.author García-Mateo, Nadia
- dc.contributor.author Cidad, Pilar
- dc.contributor.author Muñoz Aguayo, Daniel
- dc.contributor.author Puigdecanet Riubugent, Eulàlia
- dc.contributor.author Nonell Mazelon, Lara, 1972-
- dc.contributor.author Vila, Joan
- dc.contributor.author Crepaldi, Felipe M.
- dc.contributor.author Gonzalo-Calvo, David de
- dc.contributor.author Llorente-Cortés, Vicenta
- dc.contributor.author Pérez García, María Teresa
- dc.contributor.author Elosua Llanos, Roberto
- dc.contributor.author Fitó Colomer, Montserrat
- dc.contributor.author Marrugat de la Iglesia, Jaume
- dc.date.accessioned 2020-09-23T08:20:45Z
- dc.date.available 2020-09-23T08:20:45Z
- dc.date.issued 2020
- dc.description.abstract Risk prediction tools cannot identify most individuals at high coronary artery disease (CAD) risk. Oxidized low-density lipoproteins (oxLDLs) and microRNAs are actively involved in atherosclerosis. Our aim was to examine the association of CAD and oxLDLs-induced microRNAs, and to assess the microRNAs predictive capacity of future CAD events. Human endothelial and vascular smooth muscle cells were treated with oxidized/native low-density lipoproteins, and microRNA expression was analyzed. Differentially expressed and CAD-related miRNAs were examined in serum samples from (1) a case-control study with 476 myocardial infarction (MI) patients and 487 controls, and (2) a case-cohort study with 105 incident CAD cases and 455 randomly-selected cohort participants. MicroRNA expression was analyzed with custom OpenArray plates, log rank tests and Cox regression models. Twenty-one microRNAs, two previously undescribed (hsa-miR-193b-5p and hsa-miR-1229-5p), were up- or down-regulated upon cell treatment with oxLDLs. One of the 21, hsa-miR-122-5p, was also upregulated in MI cases (fold change = 4.85). Of the 28 CAD-related microRNAs tested, 11 were upregulated in MI cases -1 previously undescribed (hsa-miR-16-5p)-, and 1/11 was also associated with CAD incidence (adjusted hazard ratio = 0.55 (0.35-0.88)) and improved CAD risk reclassification, hsa-miR-143-3p. We identified 2 novel microRNAs modulated by oxLDLs in endothelial cells, 1 novel microRNA upregulated in AMI cases compared to controls, and one circulating microRNA that improved CAD risk classification.
- dc.description.sponsorship This work was supported by the Spain’s Ministry of Science and Innovation (Madrid, Spain), co-financed with European Union European Regional Development Funds –ERDF- (FIS-CP12/03287, FIS-14/00449, FIS-PI081327, INTRASALUD PI11/01801, PI15/00064, IJCI-2016-29393 to DdG-C, CIBERCV (CB16/11/00229, 00246, 00403), CIBERESP CB06/02/0029, CIBEROBN CB06/03/0028); the Spain’s ministry of Economy and Competiveness (Madrid, Spain) (BFU2016-75360-R); the BBVA Foundation (Bilbao, Spain) (PR-16-BIO-CAR-0041); the Health Departament of the Generalitat de Catalunya (Barcelona, Spain) through the Agència de Gestió d’Ajuts Universitaris de Recerca de Catalunya (AGAUR) (Barcelona, Spain) (2017SGR222), the Strategic Plan for research and health innovation (PERIS) (Barcelona, Spain) (SLT006/17/00234, SLT002/16/00145, SLT006/17/00029 to IRD); and by the Junta de Castilla y León (Valladolid, Spain) (VA114P17). CIBERs of Pathophysiology of Obesity and Nutrition (CIBEROBN), Cardiovascular Diseases (CIBERCV), and Epidemiology (CIBERESP) are initiatives of the Instituto de Salud Carlos III, Madrid, Spain.
- dc.format.mimetype application/pdf
- dc.identifier.citation Dégano IR, Camps-Vilaró A, Subirana I, García-Mateo N, Cidad P, Muñoz-Aguayo D. et al. Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals: the REGICOR Study. J Clin Med. 2020 May 9; 9(5):1402. DOI: 10.3390/jcm9051402
- dc.identifier.doi http://dx.doi.org/10.3390/jcm9051402
- dc.identifier.issn 2077-0383
- dc.identifier.uri http://hdl.handle.net/10230/45333
- dc.language.iso eng
- dc.publisher MDPI
- dc.relation.projectID info:eu-repo/grantAgreement/ES/1PE/BFU2016-75360-R
- dc.rights © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.rights.uri http://creativecommons.org/licenses/by/4.0/
- dc.subject.keyword Circulating biomarkers
- dc.subject.keyword Coronary artery disease
- dc.subject.keyword MicroRNAs
- dc.subject.keyword Myocardial infarction
- dc.subject.keyword Oxidized low-density lipoproteins
- dc.title Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals: the REGICOR Study
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/publishedVersion